Search results
Results from the WOW.Com Content Network
Through its more than 80 disease-specific financial assistance programs, PAN serves well over 100,000 patients each year from every US state and territory. [4] Without the PAN Foundation’s support, these patients would have faced impossible choices—with many simply going without their life-saving treatment.
FIND (Foundation for Innovative New Diagnostics) is a global health non-profit based in Geneva, Switzerland. FIND functions as a product development partnership, engaging in active collaboration with over 150 partners to facilitate the development, evaluation, and implementation of diagnostic tests for poverty-related diseases.
Glenn Frommer is riding across America to raise awareness for polycystic kidney disease. After This Cyclist Was Diagnosed With an Incurable Disease, He Started a Charity Ride to Fund Research Skip ...
The Pan American Health Organization (PAHO) is a specialized agency of the United Nations (UN) in charge of international health cooperation in the Americas.It fosters technical cooperation among member countries to fight communicable and noncommunicable diseases, strengthen health systems, and respond to emergencies and disasters.
A disease like osteoporosis, for example, is thought of as mostly affecting thin, elderly white women – so doctors don't always think to look outside of that population.
Irritable bowel disease (IBD), which includes ulcerative colitis or Crohn’s disease, causes inflammation in the digestive tract, leading to a range of symptoms including pain, diarrhea, and less ...
The United States President's Emergency Plan For AIDS Relief (PEPFAR) is the global health funding by the United States to address the global HIV/AIDS epidemic and help save the lives of those suffering from the disease. The U.S. allocation of over $110 billion marks the largest investment any country has ever made toward combating a single ...
The $21 million award will fund a pilot study to analyze longitudinal plasma samples covering a period of up to 10 years. This will enable researchers to track how distinct plasma proteins evolve over time in people with PD, which could help establish an early-warning system for the emergence of the disease.